Caroline Corner | Managing Director |
Michael Perry | Chief Executive Officer |
Sean Ekins | Vice President of Finance |
Josh Jennings | Cowen |
Ryan Zimmerman | BTIG |
Kevin DeGeeter | Oppenheimer |
Brooks O'Neil | Lake Street Capital Markets |
Lyanne Harrison | Bank of America Merrill Lynch |
Disclaimer: *NEW* We are providing this transcript version in a raw | machine-assisted format and it is unaudited. Please reference the audio for any questions on the content. A standard transcript will be available later on the site per our normal procedure. Please enjoy this timely version in the interim. |
[00:00:08] Ladies and gentlemen, thank you for standing by and welcome to the EBITDA Therapeutics fiscal first quarter 2020 earnings conference call at this time, all participant lines, our analyst multimode. After the speaker's presentation, there will be a question and answer session to ask the question during the session.
You need the press star one on your telephone. Please be advised that today's conference is being recorded.
If you require any further assistance, please press star zero on the Conference Board, which is speaker today.